Trial Profile
Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Mar 2020
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Fasudil (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 10 May 2017 Status changed from recruiting to completed.
- 12 Apr 2013 New trial record